MELNCT07349940
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
StatusRecruiting
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 4 words Show 4 more changesShow less
- Study completion pushed from Sep 30, 2026 to Jan 30, 2027
- Primary completion date changed from estimate of Aug 2026 to Aug 31, 2026
- Study description revised
- Site details revised at 1 of 5 sites
- Notable Trial status: Not Yet Recruiting to Recruiting
- Site details revised at 5 of 5 sites
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Potential malignancies
Timeframe: From enrollment to the end of examination - baseline.
Confirmed malignancies
Timeframe: From enrollment to the end of diagnosis at 3 months.
Confirmed malignancies by histology
Timeframe: From enrollment to the end of diagnosis at 6 months.
Arms and interventions
Adults with suspected skin lessionExperimental
Pilot screening will be conducted in general practitioners' offices, where physicians will be trained to examine skin lesions using magnifying devices (dermatoscopes) and advanced telemedicine software, enabling faster diagnostics of suspicious findings. Patients with high-risk lesions will be referred to specialized dermatology centers.
Diagnostic tests: Intervention with telemedicine tool
Sites
5 sites in 1 country